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Abstract: INTRODUCTION Open fetal myelomeningocele (fMMC) repair is nowadays a therapeutic
option in selected cases. We aimed to evaluate changes in maternal and fetal outcome after fMMC repair
during the first 8 years of experience at a tertiary referral fetal medicine center in Switzerland. -Materials
and Methods: Between 2010 and 2018, fMMC repair and delivery of the neonate via planned cesarean
section was performed in 67 cases. Cases were retrospectively stratified into 2 groups: a ”training phase”
(TP) with supervision from an external surgeon during 11 operations (2010-2014, 15 cases) followed by
an ”experienced phase” (EP, 2014-2018, 52 cases); each phase lasted about 4 years. Both phases were
compared with regard to various maternal and fetal outcome parameters. RESULTS Analyses did not
reveal differences between TP and EP in major outcome parameters such as gestational age at delivery,
chorionic membrane separation, or the incidence of placental abruption. Although more complex surgical
techniques were applied in EP (e.g., dermal closure using a rotational flap), surgery time was not different
from TP. At the same time, surgical complications such as oligohydramnios (27 vs. 8%, p = 0.046) with
MRI-confirmed leakage (13 vs. 4%, nonsignificant) and subchorionic hematoma (20 vs. 2%, p = 0.009)
were less common in EP than TP. CONCLUSIONS This study shows that the level of competence at
our center with regard to major perinatal outcome parameters was already high in the first years of
fMMC repair. However, more complex surgical techniques and significantly less minor complications
were observed during the most recent years.
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Abstract
Introduction: Open fetal myelomeningocele (fMMC) repair 
is nowadays a therapeutic option in selected cases. We 
aimed to evaluate changes in maternal and fetal outcome 
after fMMC repair during the first 8 years of experience 
at a tertiary referral fetal medicine center in Switzerland. 
 Materials and Methods: Between 2010 and 2018, fMMC re-
pair and delivery of the neonate via planned cesarean sec-
tion was performed in 67 cases. Cases were retrospectively 
stratified into 2 groups: a “training phase” (TP) with supervi-
sion from an external surgeon during 11 operations (2010–
2014, 15 cases) followed by an “experienced phase” (EP, 
2014–2018, 52 cases); each phase lasted about 4 years. Both 
phases were compared with regard to various maternal and 
fetal outcome parameters. Results: Analyses did not reveal 
differences between TP and EP in major outcome parame-
ters such as gestational age at delivery, chorionic membrane 
separation, or the incidence of placental abruption. Al-
though more complex surgical techniques were applied in 
EP (e.g., dermal closure using a rotational flap), surgery time 
was not different from TP. At the same time, surgical compli-
cations such as oligohydramnios (27 vs. 8%, p = 0.046) with 
MRI-confirmed leakage (13 vs. 4%, nonsignificant) and sub-
chorionic hematoma (20 vs. 2%, p = 0.009) were less com-
mon in EP than TP. Conclusions: This study shows that the 
level of competence at our center with regard to major peri-
natal outcome parameters was already high in the first years 
of fMMC repair. However, more complex surgical techniques 
and significantly less minor complications were observed 
during the most recent years. © 2019 S. Karger AG, Basel
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Introduction
Open in utero treatment of myelomeningocele (MMC) 
has become an optional treatment in large fetal surgery 
centers worldwide. The Management of Myelomeningo-
cele study (MOMS) has shown the benefits of open fetal 
MMC (fMMC) repair versus standard postnatal MMC 
repair for qualifying cases [1]. In the “post-MOMS era,” 
centers have been working on surgical optimization as 
well as improved perioperative management with the aim 
to overcome associated perinatal complications and risk 
factors [2–5]. 
Various studies have shown an association of intra-
uterine surgery with obstetrical complications such as 
chorioamniotic membrane separation (CMS), oligohy-
dramnios, preterm premature rupture of membranes 
(PPROM), and subsequent preterm birth with its well-
known sequelae for the premature neonate [2, 6–9].
This study aimed to compare outcome parameters in 
2 phases of surgery as well as obstetrical experience at the 




In the study interval from 12/2010 to 02/2018, a total of 67 pa-
tients underwent fMMC repair and were delivered via cesarean sec-
tion. Indication for fMMC repair was based on MOMS enrollment 
criteria [1]. All patients undergoing fMMC repair were included in 
this study, and data collection was performed prospectively.  
The protocol of patient admission and surgery preparation at 
our center required a timely on-ward administration of the gravi-
dae for fetal neuroprotection and lung maturation in fetuses ≥24 
weeks of gestational age (GA) before the actual fMMC repair. A 
postoperative MRI was conducted about 2 weeks after surgery to 
identify potential unfavorable fMMC repair complications. With 
regard to the analysis presented here, the following maternal as-
pects were evaluated: surgical hematomas and seromas, amniotic 
fluid leakage from the uterotomy, and CMS [10]. Amniotic fluid 
leakage on MRI was defined as a continuous fluid signal through 
the myometrium.
Once clinically stable after fMMC repair, patients were dis-
charged into the ambulatory setting, including weekly follow-up 
exams (ultrasound exam and CTG). Fetuses were delivered via 
elective cesarean section ideally at 37 weeks GA. Delivery was 
planned in uncomplicated cases via elective cesarean section at 37 
weeks GA. Cesarean section was preponed in cases of chorioam-
nionitis, placental abruption, and in cases of premature labor or in 
any other existent indication for immediate delivery.
Definition of “Training Phase” and “Experienced Phase”
While all surgeons involved had long-standing experience in 
postnatal MMC repair prior to starting fMMC repair, the initial 
11 fMMC cases were supervised by an external surgeon from the 
Children’s Hospital of Philadelphia. Prior to fMMC repair, the 
local obstetrical experience in periprocedural management of fe-
tal interventions was mainly based on placenta laser surgery in 
cases of twin-to-twin transfusion syndrome, along with the long-
standing experience in managing preterm gravidae. The most 
significant change in obstetrical management during the study 
period concerned a change from magnesium sulfate to atosiban 
for peri-/postoperative tocolysis after the occurrence of a third-
degree atrioventricular block (case 15). At the same time, about 
4 years after the first repair at our center, the frequency of fMMC 
repair increased considerably for various reasons (e.g., higher 
rate of international referral). Reflecting on these aspects, we ret-
rospectively defined the first 4 years of fMMC repair at our center 
as the “training phase” (TP, up to case 15). The most recent 4 
years, including 52 cases, were defined as “experienced phase” 
(EP).
Statistical Analysis
We evaluated patient characteristics, pregnancy outcomes, and 
complications during TP and EP at our center. Demographic and 
clinical variables for each phase were included: maternal age, fetal 
gender, GA at surgery, race/ethnicity, BMI, smoking status, parity, 
previous uterine surgeries, placenta location, height of fetal lesion, 
and fetal club feet. Further pregnancy complications and outcomes 
were stratified by TP and EP: subchorionic hematoma, subcutane-
ous seroma, pulmonary edema, preeclampsia/gestational hyper-
tension, oligohydramnios, MRI-confirmed amniotic fluid leakage 
from uterotomy, CMS, GA at CMS, placental abruption, gesta-
tional diabetes, PPROM, GA at PPROM, uterine rupture, pulmo-
nary embolism, perinatal death, preterm labor, GA at birth, birth 
weight, APGAR score, umbilical artery pH, and duration of sur-
gery (total and uterine). Data processing and statistical analyses 
were performed with SPSS (version 25; IBM, USA).
Data were stratified by TP and EP and presented as medians 
(interquartile ranges, IQR) or n (%). The χ2 test and Fisher’s exact 
test were applied as applicable for the comparison of nominal vari-
ables. Since all continuous variables did not match the criteria re-
quired for normal distribution based on the Shapiro-Wilkinson 
test, the Mann-Whitney U test was used to compare groups. A p 
value < 0.05 was accepted as significant.
Results
Presurgical Parameters
Table 1 provides an overview of the demographics and 
important clinical variables of the patient population. Ex-
cept for a later timing of surgery in EP versus TP (GA at 
the time of surgery 24.1 [23.7–24.7] vs. 25.3 [24.6–25.6] 
weeks in TP and EP, respectively), demographic param-
eters and general clinical variables did not differ between 
both phases. Maternal age, fetal gender, race/ethnicity, 
BMI, smoking status, parity, previous uterine surgeries, 
placenta location, fetal lesion height, and fetal club feet 
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Surgical Procedure
The total surgery time was significantly shorter in TP 
than EP (123 [110–137] vs. 141 [124–165] min; p = 0.014; 
Table 2), while we did not observe a difference in fetal 
surgery time between TP and EP (37 [30–48] vs. 42 [33–
53] min; nonsignificant). The placenta location did not 
have an impact on the operation time (137 min [125–163] 
and 135 min [120–155] for anterior placenta localization, 
p = 0.319). Fetal dura closure (60.0 vs. 96.2%, p = 0.003), 
fetal skin closure (73.3 vs. 94.2%, p = 0.020), and skin ro-
tation flaps (0 vs. 23.1% [n = 12], p = 0.040) were signifi-
cantly more commonly applied in EP cases than in the 
initial 15 TP patients (Fig. 1a). At the same time, no dif-
ference in the incidence of fetal myofascial flaps and 
patches was noted (Table 2).
Postsurgical Complications and Perinatal Outcome
Major surgical and pregnancy complications and peri-
natal outcomes are summarized in Table 3. We found sta-
tistically significant differences in hematoma and oligo-
hydramnios incidence rates in TP and EP. In the TP 
group, 3 women developed a subchorionic hematoma 
(20%) compared to only 1 case in the EP group (1.9%, 
p = 0.009; Fig.  1b). Similarly, there were significantly 
more cases of oligohydramnios during TP than EP (26.7 
vs. 7.7%, p = 0.046; Fig. 1c). The incidence of MRI-con-
firmed amniotic fluid leakage in the presence of oligohy-
dramnios demonstrated a nonsignificant trend towards a 
lower frequency in EP than TP (13.3 vs. 3.8%, nonsignif-
icant). While there was 1 perinatal death (case 2, postna-
tal death after cesarean section at 37 weeks GA with un-






Maternal age, years 29 [26–33] 32 [26–35] 0.327
Fetal gender female 9 (60%) 28 (54%) 0.673
Gestational age at surgery, weeks 24.1 [23.7–24.7] 25.3 [24.6–25.6] 0.001
Race/ethnicity 0.192
White 13 (86.7%) 50 (96.2%)
African American 1 (6.7%) 0 (0%)
Hispanic 1 (6.7%) 1 (1.9%)
Others 0 (0%) 1 (1.9%)
Maternal BMI, kg/m2 25.4 [22.7–28.4] 26.1 [23.1–30.6] 0.775
Current smokers 0 (0%) 1 (1.9%) 0.776
Primipara 9 (60%) 20 (38.5%) 0.138
Previous uterine surgeries 1 (6.7%) 7 (13.5%) 0.423
Anterior placenta 8 (53.3%) 25 (48.1%) 0.474
Fetal lesion ≤L3 13 (86.7%) 39 (75%) 0.490
Fetal club foot 1 (6.7%) 9 (17.3%) 0.436
Data are presented as n (%) or medians [interquartile ranges].






Fetal dura closure 9 (60%) 50 (96.2%) 0.003
Fetal skin closure 11 (73.3%) 49 (94.2%) 0.020
Skin rotation flap 0 (0%) 12 (23.1%) 0.040
Fetal myofascial flap 11 (73.3%) 48 (92.3%) 0.093
Patches 4 (26.7%) 23 (45.1%) 0.202
Total surgery time, min 123 [110–137] 141 [124–165] 0.014
Fetal surgery time, min 37 [30–48] 42 [33–53] 0.132
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clear etiology) in TP, EP was mortality free (p = 0.065). 
We did not observe a difference in GA at delivery between 
groups (36.1 [34.9–37.1] vs. 36.3 [34.6–37.0] weeks, p = 
0.556), but a nonsignificant trend towards a lower rate of 
premature labor in EP (66.7 vs. 40.4%, p = 0.072).
Discussion
Main Findings
The underlying study enrolled the initial 67 patients 
undergoing fMMC repair in Zurich, Switzerland. Over-
all, main outcome parameters such as GA, PPROM, 
CMS, or placental abruption did not differ between the 
initial TP and the following EP. However, with more ex-
perience, other surgical complications, such as surgical 
hematomas and oligohydramnios, became significantly 
fewer. While the duration of fetal surgery was not differ-
ent between both phases, the complexity of fMMC clo-
sure techniques increased. Of note, our main outcome 
parameters are comparable with those of the MOMS 
and post-MOMS reports by other renowned institutes 
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Training phase Experienced phase
Fig. 1. Complications after open fetal my-
elomeningocele repair by years of practice 
in 67 patients. During the training phase, 
15 patients were treated (equivalent to 4 
years). Each dot represents 1 case. a While 
total operation time increased, and fetal 
operation time did not differ between both 
phases, fetal defect closure by dura closure, 
skin closure, and skin rotation flaps was 
significantly more common in the experi-
enced phase. b Surgical hematomas (red 
dots) were more commonly encountered 
in the learning phase (20 vs. 2%, p = 0.009). 
c Oligohydramnios (red dots) were signifi-
cantly more common in the training phase 
(27 vs. 8% of cases, p < 0.045). This is in line 
with a tendency to a higher prevalence of 
MRI-confirmed leakage of amniotic fluid 


























































































Fetal MMC Repair: 8 Years of Experience 5Fetal Diagn Ther
DOI: 10.1159/000503388
Interpretations
GA at delivery was comparable to previous studies as 
34% of our women reached GA ≥37 weeks (21% in 
MOMS and 27% in the post-MOMS period at the Chil-
dren’s Hospital of Philadelphia) [1, 2], while the median 
GA at birth was not significantly higher in EP than TP. 
PPROM rates did not significantly decline in EP (33.3 vs. 
26.9%, nonsignificant), but the overall PPROM percent-
age of 28.4% of gravidae in our cohort is rather low com-
pared to PPROM rates in the MOMS cohort (46%, [1]) or 
in the post-MOMS cohorts (lowest PPROM rate of 26.7%, 
which was reported by Moron et al. [2, 4, 7, 12]), but com-
parable to PPROM rates in fetoscopic laser coagulation 
for twin-to-twin transfusion syndrome [13]. Overall 18% 
of our women (20% in TP vs. 17.3% in the EP) exhibited 
CMS (versus 26% in MOMS and 21–23% in post-MOMS 
women [1, 2, 12]), and the incidence was not reduced 
with more operative and postoperative experience. Of 
note, the CMS incidence after fetoscopy in monochori-
onic twin pregnancy widely ranges from 7 to around 21%, 
as previous studies have shown [14, 15].
Surprisingly, total surgery time was longer with more 
experience (Table 2; Fig. 1). Interestingly, fetal operation 
time was not significantly different between TP and EP 
although the type of fetal defect closure became more 
complex over time (i.e., more time-consuming skin rota-
tion flaps were introduced in EP).
Strengths and Limitations
This study represents one of the largest European case 
series of open fMMC repair, not only providing this type 
of surgical intervention to Swiss women, but also to wom-
en from a variety of other European countries. The initial 
11 open fMMC repairs were performed under the super-
vision of an external surgeon from an experienced hospi-
tal in the USA aiming at a high-quality surgical procedure 
from the first case on and further seeking adequate train-
ing of our permanent multidisciplinary team. We assume 







Subchorionic hematoma 3 (20%) 1 (1.9%) 0.009
Subcutaneous seroma 4 (26.7%) 16 (30.8%) 0.760
Uterine rupture 0 (0%) 1 (1.9%) 0.588
Oligohydramnios 4 (26.7%) 4 (7.7%) 0.046
With MRI-confirmed amniotic fluid leakage 2 (13.3%) 2 (3.8%) 0.172
Chorioamniotic membrane separation 3 (20.0%) 9 (17.3%) 0.811
PPROM 5 (33.3%) 14 (26.9%) 0.628
Gestational age at PPROM, weeks 34.9 [33.3; 35.3] 32.5 [30.5; 35.0] 0.151
Preterm labor 10 (66.7%) 21 (40.4%) 0.072
Placental abruption 0 (0%) 8 (15.4%) 0.105
Pulmonary edema 0 (0%) 2 (3.8%) 0.441
Pulmonary embolism 0 (0%) 1 (1.9%) 0.588
Prenatal death 1 (6.7%) 0 (0%) 0.061
Miscellaneous pregnancy complications
Preeclampsia/gestational hypertension 0 (0%) 2 (3.8%) 0.441
Gestational diabetes 3 (20.0%) 15 (28.8%) 0.496
Perinatal outcome parameters
Gestational age at birth, weeks 36.1 [34.9; 37.1] 36.3 [34.6; 37.0] 0.556
Gestational age at birth
≤34 0/7 weeks 2 (13.3%) 9 (17.3%) 0.714
≥37 0/7 weeks 6 (40.0%) 18 (34.6%) 0.702
Birth weight, g 2,860 [2,300; 2,950] 2,690 [2,405; 2,869] 0.250
5-min Apgar score 8 [8; 9] 9 [8; 9] 0.074
Umbilical artery pH 7.3 [7.3; 7.4] 7.3 [7.3; 7.4] 0.311
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that this strategy led to the sound results from the begin-
ning of fMMC surgery. 
Further, a tight follow-up after surgery, return to our 
institution for delivery, and subsequent neonatal treat-
ment, as well as subsequent pregnancy counseling is a 
strength of our setting. Pregnancy complications and 
outcomes were comparable to prior studies, including 
those with a higher case load [2, 7, 12]. A limitation of this 
study was the number of women (n = 67) that were en-
rolled during the study period, as this generally limits the 
power of statistical analyses. Moreover, studies examin-
ing the learning curve for fetoscopic laser surgery re-
vealed that at least 60 procedures are required to improve 
the overall outcome [13, 16].
Conclusion
In summary, we attribute the rather similar outcomes 
of TP and EP to an already high standard of surgical per-
formance from the beginning on due to the support by 
the Children’s Hospital of Philadelphia. However, the re-
duction in surgical subchorionic hematomas and oligo-
hydramnios did show a trend towards better quality of 
uterine closure with more experience. Further, more 
complex fetal defect closure techniques in EP did not pro-
long the fetal surgery time. Women opting for open 
fMMC repair should be counseled regarding the risks 
emanating from this surgical procedure, which persist 
despite increasing intra- and perioperative experience 
worldwide.
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